<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2017.01665</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Hypothesis and Theory</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Differentiation and Functionality of Bone Marrow-Derived Mast Cells Depend on Varying Physiologic Oxygen Conditions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>M&#x000F6;llerherm</surname> <given-names>Helene</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/358063"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Meier</surname> <given-names>Karsten</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/497659"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Schmies</surname> <given-names>Kathrin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fuhrmann</surname> <given-names>Herbert</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Naim</surname> <given-names>Hassan Y.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/373962"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>von K&#x000F6;ckritz-Blickwede</surname> <given-names>Maren</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/94253"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Branitzki-Heinemann</surname> <given-names>Katja</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/345957"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Physiological Chemistry, University for Veterinary Medicine Hannover</institution>, <addr-line>Hanover</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Faculty of Veterinary Medicine, Institute of Biochemistry, University of Leipzig</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><sup>3</sup><institution>Research Center for Emerging Infections and Zoonoses (RIZ), University for Veterinary Medicine Hannover</institution>, <addr-line>Hanover</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Ulrich Blank, Institut National de la Sant&#x000E9; et de la Recherche M&#x000E9;dicale, France</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Joana Vitte, Aix Marseille University, France; Silvia Bulfone-Paus, University of Manchester, United Kingdom</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Maren von K&#x000F6;ckritz-Blickwede, <email>maren.von.koeckritz-blickwede&#x00040;tiho-hannover.de</email>; Katja Branitzki-Heinemann, <email>katja.branitzki-heinemann&#x00040;tiho-hannover.de</email></corresp>
<fn fn-type="other" id="fn001"><p><sup>&#x02020;</sup>These authors have contributed equally to this work.</p></fn>
<fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1665</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>08</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 M&#x000F6;llerherm, Meier, Schmies, Fuhrmann, Naim, von K&#x000F6;ckritz-Blickwede and Branitzki-Heinemann.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>M&#x000F6;llerherm, Meier, Schmies, Fuhrmann, Naim, von K&#x000F6;ckritz-Blickwede and Branitzki-Heinemann</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Mast cells (MCs) are long-living multifunctional innate immune cells that originate from hematopoietic precursors and specifically differentiate in the destination tissue, e.g., skin, respiratory mucosa, intestine, where they mediate immune cell recruitment and antimicrobial defense. <italic>In vivo</italic> these tissues have characteristic physiological oxygen levels that are considerably lower than the atmospheric oxygen conditions (159&#x02009;mmHg, 21% O<sub>2</sub>; 5% CO<sub>2</sub>) traditionally used to differentiate MCs and to study their functionality <italic>in vitro</italic>. Only little is known about the impact of physiological oxygen conditions on the differentiation process of MCs. This study aimed to characterize the differentiation of immature murine bone marrow-derived MCs under physioxia <italic>in vitro</italic> (7% O<sub>2</sub>; 53&#x02009;mmHg; 5% CO<sub>2</sub>). Bone marrow-derived suspension cells were differentiated in the presence of interleukin-3 with continuous, non-invasive determination of the oxygen level using a Fibox4-PSt3 measurement system without technique-caused oxygen consumption. Trypan blue staining confirmed cellular viability during the specified period. Interestingly, MCs cultivated at 7% O<sub>2</sub> showed a significantly delayed differentiation rate defined by CD117-positive cells, analyzed by flow cytometry, and reached &#x0003E;95% CD117 positive population at day 32 after isolation. Importantly, MCs differentiated under physioxia displayed a decreased transcript expression level of <italic>hif-1</italic>&#x003B1; and selected target genes <italic>vegf, il-6</italic>, and <italic>tnf-</italic>&#x003B1;, but an increase of <italic>foxo3</italic> and <italic>vhl</italic> expression compared to MCs cultivated under normoxia. Moreover, the production of reactive oxygen species as well as the amount of intracellular stored histamine was significantly lower in MCs differentiated under low oxygen levels, which might have consequences for their function such as immunomodulation of other immune cells. These results show for the first time that physioxia substantially affect maturation and the properties of MCs and highlight the need to study their function under physiologically relevant oxygen conditions.</p>
</abstract>
<kwd-group>
<kwd>mast cells</kwd>
<kwd>physioxia</kwd>
<kwd>HIF-1&#x003B1;</kwd>
<kwd>FOXO3</kwd>
<kwd>histamine</kwd>
<kwd>reactive oxygen species</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="11"/>
<word-count count="7627"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>Besides their well-known role in type I hypersensitivity reactions, mast cells (MCs) are multifunctional, long living sentinel cells with a key role in the innate immune response (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). MCs derive from hematopoietic progenitor cells of the bone marrow (<xref ref-type="bibr" rid="B3">3</xref>), and circulate through the blood stream as immature precursors and lymphatics until they reach their final destination such as mucosal and epithelial tissues (<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>In the tissue, MC precursor differentiates under the influence of growth factors and cytokines that ultimately determine their mature phenotype (<xref ref-type="bibr" rid="B7">7</xref>). Two subtypes of MCs have been well characterized: mucosal MCs and connective tissue MCs (<xref ref-type="bibr" rid="B8">8</xref>). <italic>In vitro</italic> MCs differentiation is mediated by interleukin-3 (IL-3) leading phenotypically to the mucosal MC subtype (<xref ref-type="bibr" rid="B9">9</xref>). Murine bone marrow-derived MCs are commonly differentiated <italic>in vitro</italic> over 4&#x02013;6&#x02009;weeks by cultivating hematopoietic progenitor cells from murine bone-marrow in the presence of IL-3 (<xref ref-type="bibr" rid="B10">10</xref>). The differentiation status is generally confirmed by CD117/c-kit, a transmembrane protein with tyrosine kinase activity that regulates cell differentiation and proliferation (<xref ref-type="bibr" rid="B11">11</xref>). When 95% purity of mature MC suspension is reached, the cells are commonly used for functional studies (<xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B14">14</xref>). In the hematopoietic system, CD117/c-kit is expressed in most early progenitors including the stem-cell compartment (<xref ref-type="bibr" rid="B15">15</xref>). In most lineages, expression of CD117/c-kit is then lost during differentiation; only MCs maintain its expression throughout differentiation and maturation steps (<xref ref-type="bibr" rid="B16">16</xref>). For negative selection, Ly6G/C, small GPI-linked proteins on the surface of myeloid-derived cells, are used to identify neutrophils, monocytes, and granulocytes (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>).</p>
<p><italic>In vitro</italic> experiments on the functionality of MCs are normally performed under normoxic oxygen levels with normoxic differentiated bone marrow-derived cells (oxygen conditions of <italic>in vitro</italic> cell culture systems: 150&#x02009;mmHg or 19.95% oxygen, 20.3&#x02009;kPa). Importantly, maturation of MCs occur <italic>in vivo</italic> under lower oxygen levels since the destination tissues of MCs, were the final differentiation takes place, vary in their physiological oxygen levels, depending on the local need of oxygen in the tissue (<xref ref-type="bibr" rid="B19">19</xref>): bone marrow (approx. 49&#x02009;mmHg, 6.4%), blood (arterial blood: approx. 100&#x02009;mmHg, 13.2%), intestinal mucosa and submucosa (approx. 57.6&#x02009;mmHg 7.6%), alveolar wall and bronchi (gradient between 100 and 120&#x02009;mmHg in the alveolus, 13.4&#x02013;16%) (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>Furthermore, during inflammatory processes, when MCs are involved, the physiological oxygen content of the tissue, termed physioxia, locally decreases to approx. 1% due to oxygen consumption by invading host immune cells and pathogens (<xref ref-type="bibr" rid="B20">20</xref>). This decreased physiological oxygen level in the tissue is called hypoxia (<xref ref-type="bibr" rid="B19">19</xref>). Interestingly, it has been shown that MCs functions significantly differ under acute hypoxia (1% oxygen) mimicking the oxygen content of acute inflamed tissue (<xref ref-type="bibr" rid="B21">21</xref>). MCs seem to rapidly adapt to low oxygen levels to better orchestrate the immune response under hypoxia by avoiding uncontrolled degranulation and tissue damage, e.g., by downregulating important proinflammatory cytokines like TNF-&#x003B1; and increasing the release of histamine (<xref ref-type="bibr" rid="B21">21</xref>). TNF-&#x003B1; and histamine are important proinflammatory effectors stored and released upon stimulation (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). These mediators are immediately released by MCs in response to stimuli like bacteria including <italic>S. aureus</italic> to recruit other effector cells, i.e., neutrophils. Histamine increases the vascular permeability (<xref ref-type="bibr" rid="B24">24</xref>), while TNF-&#x003B1; acts as proinflammatory cytokine by recruiting and stimulating phagocytosis and degranulation of neutrophils (<xref ref-type="bibr" rid="B25">25</xref>). Since in those studies, the initial differentiation of MCs was performed under normoxic oxygen conditions, the question arises if MCs already display a distinct functional setup and gene expression when they differentiate <italic>in vitro</italic> in their physiological oxygen milieu.</p>
<p>To maintain homeostasis under low oxygen levels, the transcription factor HIF-1&#x003B1; is known to act as central regulator and key-player of the cellular adaptation to oxygen stress (<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B28">28</xref>). HIF-1&#x003B1; activity is regulated by oxygen on the protein level controlling the transcription of numerous target genes: under normoxic conditions HIF-1&#x003B1; forms a complex with VHL for proteasomal degradation (<xref ref-type="bibr" rid="B29">29</xref>), whereas it is stabilized under low oxygen conditions and subsequently translocates into the nucleus to fulfill its regulatory functions (<xref ref-type="bibr" rid="B30">30</xref>). HIF-1&#x003B1; mediates inflammatory responses in various immune cells including MCs and also affects the bactericidal capacity (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B34">34</xref>). Importantly, our own previous work revealed a minor role of HIF-1&#x003B1; in the short-term response of MCs to hypoxic 1% oxygen level (<xref ref-type="bibr" rid="B21">21</xref>). Therefore, it was of special interest to clarify the role of HIF-1&#x003B1; on MCs differentiation at physiological oxygen level.</p>
<p>We hypothesized that physiologic oxygen conditions affect the differentiation, cultivation, and functionality of MCs <italic>in vitro</italic>. Therefore, we compared the differentiation rate, transcript expression of <italic>hif-1</italic>&#x003B1;, selected target genes, <italic>foxo3</italic> and <italic>vhl</italic> as well as reactive oxygen species (ROS) production and histamine production as functional markers of MCs differentiated at 7% oxygen (here termed as physioxia) compared to MCs differentiated at atmospheric oxygen level (21%, here termed normoxia).</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>BMMC Isolation and Cultivation</title>
<p>Hematopoietic progenitor cells were isolated from femur and tibia of C57BL/6 wild-type (WT) mice. All progenitor cells derived from bones of one or two mice were pooled and again separated into two batches: one batch was cultivated under physioxic (7% O<sub>2</sub>; 53&#x02009;mmHg; 5% CO<sub>2</sub>) and the other one under normoxic (21% O<sub>2</sub>; 159&#x02009;mmHg, 5% CO<sub>2</sub>) conditions, respectively. Cells were differentiated into BMMCs (bone marrow-derived MCs) over 5&#x02013;6&#x02009;weeks in T25 suspension culture flasks (Sarstedt) under the influence of IL-3 (10&#x02009;ng/ml) as previously described (<xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
<sec id="S2-2">
<title>BMMCs Differentiation Status and Viability</title>
<p>The purity and differentiation status of BMMCs was analyzed twice a week using flow cytometry (Attune NxT Flow Cytometer; ThermoFisher Scientific) by staining the MC marker CD117/c-kit using the antibody anti-mouse CD117, PE (phycoerythrin)-labeled (12 ng/10<sup>5</sup> cells; Biolegend). Neutrophils, eosinophils, macrophages, and monocytes in the culture were stained by FITC conjugated rat anti mouse Ly-6G and Ly-6C antibody (25 ng/10<sup>5</sup> cells; BD Pharmington), or its respective isotype controls. Cellular viability was determined twice a week by counting with a Neubauer counting chamber (Marienfeld) using trypan blue (Roth, 0.4% in PBS) discrimination. All functional assays were performed, if all BMMCs were tested as 95% CD117 positive (week 6/7 post-isolation).</p>
</sec>
<sec id="S2-3">
<title>Oxygen Measurement</title>
<p>Oxygen was measured in 24-well plates (Nunc, Germany) using a Fibox4-PSt3 measurement system (PreSens Precision Sensing GmbH) as previously described (<xref ref-type="bibr" rid="B36">36</xref>). Oxygen measurements were performed over a time period of 48&#x02009;h in cell culture media and on a weekly basis in the cell suspension during the 5-week differentiation process, while the cells were incubated under physioxic (7% O<sub>2</sub>; 53&#x02009;mmHg; 5% CO<sub>2</sub>) or normoxic (21% O<sub>2</sub>; 159&#x02009;mmHg, 5% CO<sub>2</sub>) conditions, respectively.</p>
</sec>
<sec id="S2-4">
<title>Histamine Determination in the Cellular Pellet</title>
<p>Histamine levels in the cellular pellets of physioxic and normoxic differentiated BMMCs were calculated for a total of 1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> BMMCs. Cells were incubated in equilibrated complete HBSS (containing 25&#x02009;mM HEPES and 0.1% BSA) under physioxic (7% O<sub>2</sub>; 53&#x02009;mmHg; 5% CO<sub>2</sub>) or normoxic (21% O<sub>2</sub>; 159&#x02009;mmHg, 5% CO<sub>2</sub>) conditions, respectively. BMMCs were treated and prepared as described earlier (<xref ref-type="bibr" rid="B21">21</xref>) with the MC-degranulating peptide mastoparan (50&#x02009;&#x000B5;M; Bachem, Heidelberg, Germany) as a positive control or without external stimulation (spontaneous release) for 45&#x02009;min in a volume of 100&#x02009;&#x000B5;l complete HBSS. The histamine content was measured by rpHPLC as previously described by Gueck et al. (<xref ref-type="bibr" rid="B37">37</xref>).</p>
</sec>
<sec id="S2-5">
<title>RNA Expression Analysis</title>
<p>Previous to RNA isolation 1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> BMMCs were incubated under normoxia or physioxia for 3&#x02009;h in IMDM (supplemented with 0.1&#x02009;mM MEM and 2% of 70&#x000B0;C h.i. FCS) in a 1.5-ml reaction tube. RNA was extracted with the RNeasy Mini Kit (Qiagen) by following the user&#x02019;s manual. The quality of RNA was tested with a bioanalyzer (RNA 6000 Pico Kit, Agilent) as described in the manufacturer&#x02019;s instructions. The RNA quality scoring and RT-qPCR was done as previously described (<xref ref-type="bibr" rid="B21">21</xref>). Finally, physioxia and normoxia values were normalized to the housekeeping gene <italic>rps9</italic> using the &#x00394;Ct method: Ct (cycle threshold) is defined as the number of cycles required for the fluorescent signal to cross the threshold. Ct levels are inversely proportional to the amount of target nucleic acid in the sample (i.e., the higher the Ct level the lower the amount of target nucleic acid in the sample). Respective oligonucleotide primers used for RT-qPCR are listed in Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Oligonucleotide primers used in RT-qPCR.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Primer</th>
<th valign="top" align="left">Accession number</th>
<th valign="top" align="left">Sequence (sense, antisense)</th>
<th valign="top" align="center">RNA/DNA</th>
<th valign="top" align="center">Tm&#x000B0;C</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="2"><italic>rsp9</italic></td>
<td align="left" valign="top" rowspan="2">NM_029767</td>
<td align="left" valign="top">Forward primer TTGTCGCAAAACCTATGTGACC</td>
<td align="center" valign="top" rowspan="2">147/344</td>
<td align="center" valign="top">61.1</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer GCCGCCTTACGGATCTTGG</td>
<td align="center" valign="top">62.8</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><hr/></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2"><italic>tnf-&#x003B1;</italic></td>
<td align="left" valign="top" rowspan="2">X02611</td>
<td align="left" valign="top">Forward primer CCTGTAGCCCACGTCGTAG</td>
<td align="center" valign="top" rowspan="2">148/442</td>
<td align="center" valign="top">61.5</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer GGGAGTAGACAAGGTACAACCC</td>
<td align="center" valign="top">61.4</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><hr/></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2"><italic>il-6</italic></td>
<td align="left" valign="top" rowspan="2">NM_031168</td>
<td align="left" valign="top">Forward primer CTGCAAGAGACTTCCATCCAG</td>
<td align="center" valign="top" rowspan="2">131/&#x02013;</td>
<td align="center" valign="top">60.1</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer AGTGGTATAGACAGGTCTGTTGG</td>
<td align="center" valign="top">60.8</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><hr/></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2"><italic>hif-1</italic>&#x003B1;</td>
<td align="left" valign="top" rowspan="2">NM_001313919.1</td>
<td align="left" valign="top">Forward primer CATCCAGAAGTTTTCTCACACG</td>
<td align="center" valign="top" rowspan="2">138/&#x02013;</td>
<td align="center" valign="top">63.5</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer GGCGAAGCAAAGAGTCTGAA</td>
<td align="center" valign="top">64.5</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><hr/></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">vegf</td>
<td align="left" valign="top" rowspan="2">AY707864.1</td>
<td align="left" valign="top">Forward primer AGTCCCATGAAGTGATCAAGTTCA</td>
<td align="center" valign="top" rowspan="2">220/730</td>
<td align="center" valign="top">65.7</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer ATCCGCATGATCTGCATGG</td>
<td align="center" valign="top">67.2</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><hr/></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2"><italic>foxo3</italic></td>
<td align="left" valign="top" rowspan="2">NM_019740.2</td>
<td align="left" valign="top">Forward primer CTGCTCGTGGAAGGGAGGAGGA</td>
<td align="center" valign="top" rowspan="2">181/&#x02013;</td>
<td align="center" valign="top">65.43</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer GAGCTCCAGCTCGGCTCCTT</td>
<td align="center" valign="top">64.10</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><hr/></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2"><italic>vhl</italic></td>
<td align="left" valign="top" rowspan="2">NM_009507.3</td>
<td align="left" valign="top">Forward primer GCGAATCCGAGGGACCCGTT</td>
<td align="center" valign="top" rowspan="2">435/&#x02013;</td>
<td align="center" valign="top">64.69</td>
</tr>
<tr>
<td align="left" valign="top">Reverse primer TGACCAGGCTCCGCACAACC</td>
<td align="center" valign="top">65.15</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="S2-6">
<title>ROS Determination</title>
<p>A total of 2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> BMMCs were centrifuged at 90&#x02009;&#x000D7;&#x02009;<italic>g</italic> and resuspended in 500&#x02009;&#x000B5;l oxygen equilibrated IMDM (supplemented with 0.1&#x02009;mM MEM and 2% of 70&#x000B0;C h.i. FCS) as negative control, phorbol 12-myristate 13-acetate (PMA, 25&#x02009;nM; Sigma) in IMDM as positive control. BMMCs, differentiated under physioxia (159&#x02009;mmHg, 21% O<sub>2</sub>; 5% CO<sub>2</sub>) were stimulated for 45&#x02009;min in a 1.5-ml reaction tube. BMMCs, differentiated under normoxia (7&#x02009;mmHg, 1% O<sub>2</sub>; 5% CO<sub>2</sub>) were stimulated for 45&#x02009;min in normoxic oxygen levels, respectively. For further examinations, normoxically differentiated cells were preincubated 3&#x02009;h under physioxia or normoxia before stimulation. ROS production was quantified by dichlorofluorescein (DCF; Sigma) using flow cytometry (Attune NxT Flow Cytometer; ThermoFisher Scientific). DCF was added at a final concentration of 10&#x02009;&#x000B5;M, 15&#x02009;min before the treatment incubation ended, for a total of 30&#x02009;min. Mean green fluorescence intensity of all (X-Mean of BL-1) was recorded and represents the mean ROS production.</p>
</sec>
<sec id="S2-7">
<title>Statistical Analysis</title>
<p>If not indicated otherwise for each experimental setup, at least three independent experiments using at least three MC batches were performed. Data analysis was performed using Excel 2010 (Microsoft) and GraphPad Prism 7.0 (GraphPad Software). Differences between two groups were analyzed by using an unpaired, two-tailed Student&#x02019;s <italic>t</italic>-test, if not otherwise stated. The significance is indicated as follows: ns, not significant, &#x0002A;<italic>p</italic>&#x02009;&#x02264;&#x02009;0.05, &#x0002A;&#x0002A;<italic>p</italic>&#x02009;&#x02264;&#x02009;0.01, &#x0002A;&#x0002A;&#x0002A;<italic>p</italic>&#x02009;&#x02264;&#x02009;0.001, and &#x0002A;&#x0002A;&#x0002A;&#x0002A;<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.0001.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title>Oxygen Concentration in the Cell Media and Culture Suspension</title>
<p>Hematopoietic progenitor cells were isolated from the bone marrow of C57BL/6 WT mice and differentiated in the presence of IL-3 for 39&#x02009;days under physiological oxygen conditions in comparison to atmospheric oxygen conditions. The experimental settings of cultivating MCs under physioxia were monitored over the whole differentiation period by measuring the oxygen content in the cell suspension with continuous, non-invasive determination of the oxygen level using a Fibox4-PSt3 measurement system (PreSens<sup>&#x000AE;</sup>). The oxygen level stabilizes at around 53&#x02009;mmHg (7% O<sub>2</sub>), while the normoxic remains above 120&#x02009;mmHg (16% O<sub>2</sub>) in media alone as well as in the cell suspension (Figure <xref ref-type="fig" rid="F1">1</xref>), confirming that MCs do not massively consume oxygen in the culture media during differentiation. To evaluate the time needed for the media to equilibrate to physioxic or normoxic oxygen levels, the oxygen content was monitored up to 48&#x02009;h under hypoxia. The oxygen level equilibrates after 1.5&#x02009;h and stays constant for up to 48&#x02009;h (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Oxygen concentration in media without (left, monitored up to 48&#x02009;h under physioxia) and in BMMC suspension culture (right, monitored every week) under normoxia and physioxia, measured using a Fibox4-PSt3 measurement system (PreSens<sup>&#x000AE;</sup>). The oxygen level of both media alone as well as in the cell suspension stabilizes at around 53&#x02009;mmHg (7% O<sub>2</sub>) und physioxia, while the normoxic remains above 120&#x02009;mmHg (16% O<sub>2</sub>). Equilibration of the media is reached after approx. 1.5&#x02009;h. Depicted are the mean values and SDs of <italic>n</italic>&#x02009;&#x0003D;&#x02009;4 experiments with cells derived from 4 mice (not pooled).</p></caption>
<graphic xlink:href="fimmu-08-01665-g001.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title>Cell Viability</title>
<p>The viability of MC progenitor cells under physioxia compared to normoxia was evaluated by counting the cells in trypan blue. Total cell number decreases in the beginning and remains constant at approx. 1&#x02009;&#x000D7;&#x02009;10<sup>7</sup> 10&#x02009;days post-isolation under normoxia and physioxia, respectively (Figure <xref ref-type="fig" rid="F2">2</xref>A). The primary loss of cells in the first week of cultivation is due to strong selection of the initially very heterogeneous bone-marrow derived cell population. After this initial loss of mainly adherent and immature immune cells that might die due to a lack in, e.g., growth factors, the cell number stays constant, indicating that no significant differences in cell survival and cell number are observable under physioxia compared to normoxia.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>(A)</bold> Total cell count of viable cells was determined by counting with a Neubauer counting chamber using trypan blue discrimination. No significant differences in cell survival and cell number are observable under physioxia compared to normoxia. The initial loss of cells in the first week of cultivation is due to strong selection of the primarily very diverse bone marrow-derived cell population. Depicted are mean values and SEM from cell suspensions of <italic>n</italic>&#x02009;&#x0003D;&#x02009;3 separated BMMC-batches derived from three mice (not pooled). <bold>(B)</bold> Time-dependent CD117 expression as marker for mast cell (MC) differentiation. Increasing CD117 expression over time indicates progressing MC differentiation that is slightly but significantly delayed under physioxic culture conditions compared to normoxia at day 21 and 25 post-isolation. Depicted are mean values and SEM from cell suspensions of <italic>n</italic>&#x02009;&#x0003D;&#x02009;3 separated BMMC-batches derived from three mice (not pooled). <bold>(C)</bold> Representative dot blot diagrams of Ly6 G/C- and CD117-labeled cells on day 0, 25, and 35 post-isolation, cultivated under normoxia or physioxia. Cells were stained for the surface markers Ly6 G/C and CD117. Q1: Ly6 G/C positive cells, Q2: double positive cells, Q3: CD117 positive cells, Q4: double negative cells. Independent of the oxygen level, the number of Ly6 G/C-positive cells decreases while the amount of CD117-positive cells increases during cultivation.</p></caption>
<graphic xlink:href="fimmu-08-01665-g002.tif"/>
</fig>
</sec>
<sec id="S3-3">
<title>Differentiation Status of MCs</title>
<p>The differentiation status was monitored using flow cytometry with cell-specific surface markers: Ly6 G/C is a marker for neutrophils and monocytes and CD117/c-kit receptor for mature MCs. Increasing CD117 expression over time indicates progressive MC differentiation that is slightly but significantly delayed under physioxic culture conditions compared to normoxia at day 21 (mean difference to normoxic differentiated cells: 11.1%) and 25 (mean difference to normoxic differentiated cells: 17.08%) post-isolation. Final differentiation rate averages more than 95% after 39&#x02009;days in all samples (Figures <xref ref-type="fig" rid="F2">2</xref>B,C). Independent of the oxygen level, the number of Ly6 G/C-positive cells decreases, while the amount of CD117-positive cells increases during cultivation (Figure <xref ref-type="fig" rid="F2">2</xref>C).</p>
</sec>
<sec id="S3-4">
<title>Transcription Expression of Selected Target Genes Known to Modulate Cellular Function in Response to Oxygen</title>
<p>To evaluate possible changes in gene expression of differentiated mature MCs, the transcript expression of <italic>hif-1</italic>&#x003B1; and some selected regulated HIF-1&#x003B1; target genes were measured <italic>via</italic> qRT-PCR at day 39 after isolation when cells were more than 95% positive for CD117. MCs differentiated under physioxia exhibit a significantly lower transcript expression of <italic>hif-1</italic>&#x003B1; (Normoxia &#x00394;Ct 15.2&#x02009;&#x000B1;&#x02009;0.14 versus physioxia &#x00394;Ct 15.94&#x02009;&#x000B1;&#x02009;0.29), <italic>tnf-</italic>&#x003B1; (Normoxia &#x00394;Ct 5.38&#x02009;&#x000B1;&#x02009;0.11 versus physioxia &#x00394;Ct 7.33&#x02009;&#x000B1;&#x02009;0.14), <italic>il-6</italic> (Normoxia &#x00394;Ct 6.20&#x02009;&#x000B1;&#x02009;0.053 versus physioxia &#x00394;Ct 7.75&#x02009;&#x000B1;&#x02009;0.15), and <italic>vegf</italic> (Normoxia &#x00394;Ct 5.71&#x02009;&#x000B1;&#x02009;0.08 versus physioxia &#x00394;Ct 6.44&#x02009;&#x000B1;&#x02009;0.17) compared to normoxia, depicted here as &#x00394;CT values (Figures <xref ref-type="fig" rid="F3">3</xref>A&#x02013;D).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>(A&#x02013;D)</bold> Transcript expression of <italic>hif-1</italic>&#x003B1;, <italic>vegf, tnf-</italic>&#x003B1;, and <italic>il-6</italic> in MCs differentiated under physioxia compared to normoxia. MCs differentiated under physioxia display a significant lower transcript expression of <italic>hif-1</italic>&#x003B1;, <italic>tnf-</italic>&#x003B1;, <italic>il-6</italic>, and <italic>vegf</italic> compared to normoxia. Transcript expression of <bold>(E)</bold> <italic>foxo3</italic> and <bold>(F)</bold> <italic>vhl</italic> in MCs demonstrate that <italic>foxo3</italic> is significantly upregulated by comparing physioxic versus normoxic differentiated MCs. The expression of <italic>vhl</italic> shows a tendency (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.077) to be upregulated under physioxia compared to normoxia. Depicted are the mean values and SDs of <italic>n</italic>&#x02009;&#x0003D;&#x02009;4 experiments with cells derived from four mice (not pooled). <bold>(G&#x02013;L)</bold> Transcript expression of <italic>hif-1</italic>&#x003B1;, <italic>vegf, tnf-</italic>&#x003B1;, <italic>il-6, foxo3</italic>, and <italic>vhl</italic> in MCs of normoxic differentiated cells and a following short-term (3&#x02009;h) stimulation under physioxia compared to normoxia. No difference in &#x00394;Ct values of <italic>hif-1</italic>&#x003B1;, <italic>tnf-</italic>&#x003B1;, <italic>vegf, foxo3</italic>, and <italic>vhl</italic> was observable. Expression of <italic>il-6</italic> was significantly increased under physioxia compared to normoxia. Physioxia and normoxia values were normalized to the housekeeping gene <italic>rps9</italic> using the &#x00394;Ct method: Ct (cycle threshold) is defined as the number of cycles required for the fluorescent signal to cross the threshold. Ct levels are inversely proportional to the amount of target nucleic acid in the sample (i.e., the higher the Ct level the lower the amount of target nucleic acid in the sample). Depicted are the mean values and SDs of <italic>n</italic>&#x02009;&#x0003D;&#x02009;3 experiments with cells derived from six mice (two mice pooled for each batch). Statistical differences were analyzed using a paired, two-tailed Student&#x02019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fimmu-08-01665-g003.tif"/>
</fig>
<p>Besides HIF-1&#x003B1;, the FOXO3 transcription factor is known to play a role in adaptation to oxygen stress (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). To unravel if FOXO3 is differentially expressed during physioxic differentiation in MCs and if it may have an effect on HIF-1&#x003B1; degradation through the direct upregulation of <italic>vhl</italic>, gene expression of <italic>foxo3</italic> and its recently shown target <italic>vhl</italic> was conducted (<xref ref-type="bibr" rid="B39">39</xref>). As shown in Figure <xref ref-type="fig" rid="F3">3</xref>E, the expression of <italic>foxo3</italic> was significantly upregulated comparing physioxic (&#x00394;Ct 8.81&#x02009;&#x000B1;&#x02009;0.075, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4) versus normoxic (&#x00394;Ct 10.44&#x02009;&#x000B1;&#x02009;0.18, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4) differentiated MCs. The expression of <italic>vhl</italic> shows a tendency (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.077) to be downregulated under physioxia (&#x00394;Ct 6.24&#x02009;&#x000B1;&#x02009;0.11, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4) compared to normoxia (&#x00394;Ct 0.77&#x02009;&#x000B1;&#x02009;0.23, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4) (Figure <xref ref-type="fig" rid="F3">3</xref>F).</p>
<p>To confirm that the difference in gene expression is a direct effect of differentiation under physioxia, short-term physioxia was used for verification of gene expression of <italic>hif-1</italic>&#x003B1;, <italic>tnf-</italic>&#x003B1;, <italic>il-6, vegf, foxo3</italic>, and <italic>vhl</italic> compared to normoxia. The transcript expression of MCs differentiated under normoxia and challenged for 3&#x02009;h with 7% O<sub>2</sub> was evaluated. No difference in &#x00394;Ct in <italic>hif-1</italic>&#x003B1;, <italic>tnf-</italic>&#x003B1;, <italic>vegf, foxo3</italic>, and <italic>vhl</italic> was observed (Figures <xref ref-type="fig" rid="F3">3</xref>G&#x02013;I,K,L). Even so, the expression of <italic>il-6</italic> was significantly increased after short-term incubation under physioxia (normoxia: &#x00394;Ct 7.82&#x02009;&#x000B1;&#x02009;0.73, <italic>n</italic>&#x02009;&#x0003D;&#x02009;3; physioxia: &#x00394;Ct 7.18&#x02009;&#x000B1;&#x02009;0.67, <italic>n</italic>&#x02009;&#x0003D;&#x02009;3) (Figure <xref ref-type="fig" rid="F3">3</xref>J).</p>
</sec>
<sec id="S3-5">
<title>Generation of ROS</title>
<p>Reactive oxygen species are essential mediators of inflammation, playing a role in innate immune signaling (<xref ref-type="bibr" rid="B40">40</xref>) and have a direct biocidal effect on invading bacteria. Detrimental effects are also known: ROS may damage the host cells (<xref ref-type="bibr" rid="B41">41</xref>). Therefore, ROS production must be tightly regulated for maintaining host cell homeostasis in case of infection. ROS production in MCs differentiated under physioxia or normoxia was analyzed by flow cytometry by conducting the X-Mean green fluorescence intensity of each cell (Figure <xref ref-type="fig" rid="F4">4</xref>A). The results show that PMA (normoxia: 3,553&#x02009;&#x000B1;&#x02009;476.1, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4; physioxia: 1,674&#x02009;&#x000B1;&#x02009;116.7, <italic>n</italic>&#x02009;&#x0003D;&#x02009;3) significantly induces ROS production under both conditions in comparison to the unstimulated control (normoxia: 1,691&#x02009;&#x000B1;&#x02009;210, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4; physioxia: 899&#x02009;&#x000B1;&#x02009;114, <italic>n</italic>&#x02009;&#x0003D;&#x02009;3). By comparing physioxic versus normoxic differentiated MC, overall ROS production was significantly reduced when cells were differentiated at 7% oxygen in the control group, this effect was not significant when cells were incubated only for 3&#x02009;h at 7% oxygen.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>(A)</bold> Reactive oxygen species (ROS) production of mast cells (MCs) differentiated under physioxia compared to normoxia. The results display that PMA (25&#x02009;nM) induces ROS production in MCs in both conditions. By comparing physioxic versus normoxic differentiated MC, ROS production is significantly and drastically reduced. Depicted are mean values and SEM from cells of <italic>n</italic>&#x02009;&#x0003D;&#x02009;4 (eight mice, two mice pooled for each batch) experiments for normoxic cultivated MCs and <italic>n</italic>&#x02009;&#x0003D;&#x02009;3 (six mice, two mice pooled for each batch) for physioxic cultivated MCs. <bold>(B)</bold> ROS production of MCs differentiated under normoxia and pre-incubated for 3&#x02009;h (short-term) under physioxia in comparison to normoxia. PMA stimulated MCs significantly produce more ROS under short-term physioxia and normoxia. By comparing short-term physioxia versus normoxia, PMA stimulated ROS production is significantly decreased under physioxia. Depicted are mean values and SEM from cells of <italic>n</italic>&#x02009;&#x0003D;&#x02009;4 (eight mice, two mice pooled for each batch) experiments. ROS production was analyzed by flow cytometry using the DCF-fluorescence based method. Depicted is the X-mean green fluorescence intensity of each cell. Differences within one group were analyzed by using a paired, two-tailed Student&#x02019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fimmu-08-01665-g004.tif"/>
</fig>
<p>To test, whether this effect is due to differentiation of MCs under physioxia or due to physioxic oxygen alone, short-term ROS production was measured with normoxically differentiated MCs after 3&#x02009;h exposure to physioxia (Figure <xref ref-type="fig" rid="F4">4</xref>B). In this experiment, also PMA stimulated MCs significantly to produce ROS under short-term physioxia and normoxia (normoxia: 4,859&#x02009;&#x000B1;&#x02009;316.3, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4; physioxia: 3,658&#x02009;&#x000B1;&#x02009;382.3, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4) in comparison to their respective control (normoxia: 3,138&#x02009;&#x000B1;&#x02009;475.1, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4; physioxia: 2,611&#x02009;&#x000B1;&#x02009;486, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4). By comparing short-term physioxia versus normoxia, PMA stimulated ROS production is significantly decreased under physioxia. Overall a decreased ROS production was more pronounced in MCs differentiated under physioxia, thus confirming the direct effect of physioxic differentiation on ROS production.</p>
</sec>
<sec id="S3-6">
<title>Intracellular Histamine Levels</title>
<p>Histamine is a key mediator in effector cell recruitment and is released by MCs. The impact of physioxia on the functionality of MCs after maturation under physiologic oxygen conditions was ascertained by investigating histamine levels with high performance liquid chromatography (HPLC). The amount of intracellular histamine is significantly reduced in MCs differentiated under low oxygen levels (Figure <xref ref-type="fig" rid="F5">5</xref>A). Under normoxia, a mean of 0.89&#x02009;&#x000B1;&#x02009;0.078&#x02009;&#x000B5;g histamine/ml was measured, while under physioxia this level is reduced (0.12&#x02009;&#x000B1;&#x02009;0.03&#x02009;&#x000B5;g histamine/ml). To determine if this effect is specific for physioxic differentiation, cellular histamine level after short-term physioxia (3&#x02009;h) was measured in normoxically differentiated cells (Figure <xref ref-type="fig" rid="F5">5</xref>B). No difference in histamine storage could be observed (normoxia: 0.96&#x02009;&#x000B1;&#x02009;0.079, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4; physioxia: 1.173&#x02009;&#x000B1;&#x02009;0.140, <italic>n</italic>&#x02009;&#x0003D;&#x02009;4), confirming the effect of physioxic differentiation.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>(A)</bold> Intracellular histamine storage after physioxic differentiation measured by high performance liquid chromatography. The amount of intracellular stored histamine is significantly reduced in MCs differentiated under low oxygen levels. Depicted are mean values and SEM from cells of <italic>n</italic>&#x02009;&#x0003D;&#x02009;6 individual BMMC batches. <bold>(B)</bold> Intracellular histamine storage of normoxic differentiated cell after short-term (3&#x02009;h) physioxia in comparison to normoxia. No difference in intracellular storage of histamine is observed. Depicted are single values and SEM from cells of minimum <italic>n</italic>&#x02009;&#x0003D;&#x02009;3 (six mice, two mice pooled for each batch) individual experiments.</p></caption>
<graphic xlink:href="fimmu-08-01665-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>It is well known that reduced oxygen levels, which predominantly occur during infection and inflammation, have an important impact on immune cell functions <italic>in vitro</italic> (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B34">34</xref>). However, the importance of oxygen on differentiation of MCs <italic>in vitro</italic> is still not completely understood, although it is well known that the physiological oxygen level in resident tissues&#x02014;the place where immature precursors differentiate to mature MCs&#x02014;are much lower than atmospheric oxygen concentrations (<xref ref-type="bibr" rid="B19">19</xref>). Nowadays, the importance of this fact is increasing, especially regarding the reproducibility of <italic>in vitro</italic> culture systems when focusing on oxygen levels in immunological studies, as recently reviewed by Zenewicz (<xref ref-type="bibr" rid="B42">42</xref>). Our own previous studies with neutrophils or MCs revealed that there is an immune cell-specific response to hypoxic (1%) oxygen conditions that differs from the normoxic phenotype (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Here, we investigated the impact of reduced physioxic (7%) oxygen level on the differentiation of bone marrow-derived hematopoietic stem cells into mature MCs.</p>
<p>By cultivating MCs under physioxia (7% O<sub>2</sub>), no difference in cell viability and cell number was observed over 39&#x02009;days of differentiation compared to normoxic (21% O<sub>2</sub>) differentiation (Figure <xref ref-type="fig" rid="F2">2</xref>A). Interestingly, for other cell types, it is known that physioxia and prolonged hypoxia influence the cellular survival: e.g., human fibroblasts increase their lifespan by 25% under 10% O<sub>2</sub> compared to normoxically cultivated cells (<xref ref-type="bibr" rid="B43">43</xref>). For primary neutrophils, it was also shown that culturing under hypoxia protects from apoptosis (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B44">44</xref>). In stem cell biology, the culturing of cells under low oxygen already found its way into routine. Culturing embryonic stem cells at 5% oxygen retains their pluripotency (<xref ref-type="bibr" rid="B45">45</xref>). Importantly, Gornostaeva and colleagues conclude from their results that &#x0201C;the &#x02018;hypoxic&#x02019; phenotype of ASCs (allogeneic adipose tissue-derived multipotent mesenchymal stem cells) may be more &#x02018;desirable&#x02019; for the interaction with allogeneic immune cells&#x0201D; (<xref ref-type="bibr" rid="B46">46</xref>). In addition, oxygen is considered as an important signaling molecule, which has an integral role in the hematopoietic stem cell maintenance as well as in stem cell proliferation and differentiation (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>Although no difference in cell viability was observed in this study (Figure <xref ref-type="fig" rid="F2">2</xref>A), the differentiation rate was found to be significantly slower on day 21 and 25 post-isolation under physioxic compared to normoxic differentiated MCs (Figures <xref ref-type="fig" rid="F2">2</xref>B,C). Interestingly, K&#x000F6;hler et al. (<xref ref-type="bibr" rid="B48">48</xref>) showed in 2012 that the differentiation of bone marrow-derived dendritic cells (BMDCs) under hypoxia (1% O<sub>2</sub>) leads to enhanced phenotypic maturation into mature BMDCs but reduced cell growth and production of several cytokines. This was independent of HIF-1&#x003B1;, as shown by using mice with a conditional deletion of HIF-1&#x003B1; in dendritic cells. In good correlation to these data, we found that the transcript expression of <italic>hif-1</italic>&#x003B1; and selected target genes is downregulated in MCs cultured under physioxia (Figures <xref ref-type="fig" rid="F3">3</xref>A&#x02013;D). The data support the assumption that under physioxia HIF-1&#x003B1; plays only a minor role during MC differentiation.</p>
<p>Possible candidates for an alternative response to stress stimuli including oxygen stress are Forkhead transcription factors (FOXO) (<xref ref-type="bibr" rid="B38">38</xref>). Mammalian cells express four FOXO factors: FOXO1, FOXO3a, FOXO4, and FOXO6. These factors are evolutionarily conserved and also identified in <italic>C. elegans</italic>, here named as DAF-16. DAF-16 promotes a developmental stage of <italic>C. elegans</italic> that ensures survival under nutrient-poor conditions (<xref ref-type="bibr" rid="B49">49</xref>). FOXO3 is the main factor detected in the thymus and bone marrow (<xref ref-type="bibr" rid="B38">38</xref>). Beside their role as tumor suppressors in several systems (<xref ref-type="bibr" rid="B50">50</xref>), they are identified to play a role in the adaptation of the cell to hypoxic stress. Thereby, especially FOXO3 antagonizes cMyc function, which results in downregulation of mitochondrial activity, thus preventing hypoxia-induced ROS formation which would consequently result in HIF-1&#x003B1; stabilization (<xref ref-type="bibr" rid="B51">51</xref>&#x02013;<xref ref-type="bibr" rid="B53">53</xref>). We show here, that <italic>foxo3</italic> expression is significantly increased in MCs cultivated under physioxia (Figure <xref ref-type="fig" rid="F3">3</xref>E), along with reduced <italic>hif-1</italic>&#x003B1; expression (Figure <xref ref-type="fig" rid="F3">3</xref>A), suggesting that FOXO3 plays also a role in differentiation of MCs under physioxia and may also play a role in the downregulation of <italic>hif-1</italic>&#x003B1;. Controversially to this suggestion, it was published that FOXO3 is activated downstream of HIF-1&#x003B1; in fibroblasts as well as in breast cancer cells (<xref ref-type="bibr" rid="B54">54</xref>). Consequently, MCs upregulation of <italic>foxo3</italic> might occur in a HIF-1&#x003B1;-independent manner or even HIF-1&#x003B1; degradation occurs. Nevertheless, further studies are needed to unravel the role of FOXO3 and HIF-1&#x003B1; as well as their interplay during physioxic differentiation of innate immune cells.</p>
<p>Liu et al. recently showed in a zebrafish model that FOXO3 directly binds to VHL, an E3 ubiquitin ligase complex that is responsible for HIF-1&#x003B1; degradation. They stated that in zebrafish the disruption of <italic>foxo3b</italic> (the homolog of <italic>foxo3</italic> in human) led to impaired hypoxic tolerance and discussed that this might also be due to the influence of <italic>foxo3b</italic> on HIF activity <italic>via</italic> regulation of <italic>vhl</italic>. The expression of <italic>vhl</italic> is downregulated in MCs differentiated under physioxia, though this effect is not significant (Figure <xref ref-type="fig" rid="F3">3</xref>F). Possibly, MCs differentiate under physioxia by expressing <italic>foxo3</italic> and <italic>vhl</italic>, leading to degradation of HIF-1&#x003B1;.</p>
<p>Besides antimicrobial activities of immune cells, like phagocytosis, mediator-, and extracellular traps release, ROS play a central role in directly killing pathogens or mediating inflammation (<xref ref-type="bibr" rid="B55">55</xref>). ROS include, e.g., superoxide anions <inline-formula><mml:math id="M1"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mrow><mml:mo>&#x022C5;</mml:mo><mml:mo>&#x02212;</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula>, hydrogen peroxides (H<sub>2</sub>O<sub>2</sub>), and hydroxyl radicals (OH<sup>&#x022C5;</sup>), and others that confer reactivity to different biological targets (<xref ref-type="bibr" rid="B56">56</xref>). One example is lysosomal digestion of pathogens after phagocytosis, by enzymes and <italic>H<sub>2</sub>O<sub>2</sub></italic> (<xref ref-type="bibr" rid="B57">57</xref>). Moreover, ROS stimulate the production of proinflammatory cytokines (<xref ref-type="bibr" rid="B58">58</xref>) and are discussed as second messenger in signal transduction (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Increased production results in hyperactivation of inflammatory responses, tissue damage and disease (<xref ref-type="bibr" rid="B41">41</xref>). MCs are well known to be strongly involved in acute lung injury and tissue damage due to MC degranulation and systemically circulating ROS (<xref ref-type="bibr" rid="B61">61</xref>). The additional production of ROS by activated MCs tremendously alters the risk for injury severity; therefore, ROS-generation needs to be strictly controlled. MCs differentiated under physioxia produce significantly less ROS without or with stimulus (PMA) (Figure <xref ref-type="fig" rid="F4">4</xref>A). Since it is published that acute hypoxia increases ROS production in MCs and various other cell types (<xref ref-type="bibr" rid="B62">62</xref>), ROS production might be otherwise regulated and strictly controlled in MCs during physioxic differentiation. A possible explanation might be the relation of mitochondrial ROS production and FOXO3. As already mentioned, FOXO3a could be a down-regulator of HIF-1&#x003B1;. Interestingly, FOXO3a activation blocks the hypoxia-dependent increase in ROS in colon cancer cells and prevents HIF-1&#x003B1; stabilization (<xref ref-type="bibr" rid="B53">53</xref>). In another study, it was demonstrated that FOXO3a protects quiescent cells from oxidative stress by inducing manganese superoxide dismutase (Mn-SOD), leading to less ROS. The fact that hypoxia increases cellular ROS production, could lead to the conclusion that the decreased ROS level under physioxia could prevent detrimental accumulation of ROS in MCs. One hind for this hypothesis is the increased expression level of <italic>foxo3</italic> during physioxic differentiation, which could decrease ROS by inducing the expression of antioxidant enzymes, like Mn-SOD. By analyzing ROS production in response to short-term physioxia, we could also confirm that this effect is due to physioxic differentiation.</p>
<p>A key function of MCs is the release of mediators to mediate the recruitment of effector cells and orchestrate the immune response. One of the most important mediators of MCs is histamine, which was shown to be significantly and drastically decreased intracellularly under physioxia, suggesting an impact of physioxic differentiation on secretory granule composition. Histamine increases vascular permeability to enhance the blood flow and to allow the recruitment of other effector cells. Furthermore, histamine enhances epithelial cell mucus production to avoid bacterial residence (<xref ref-type="bibr" rid="B1">1</xref>). The observed decreased histamine storage after differentiation under physioxia (Figure <xref ref-type="fig" rid="F5">5</xref>A) may decrease the vasoactive capability of MCs, thus antimicrobial activity during infection is impaired. The intracellular storage after short-term physioxic incubation was not affected, thus the effect of physioxic differentiation on histamine storage was confirmed (Figure <xref ref-type="fig" rid="F5">5</xref>B). Nevertheless, histamine storage was reduced after physioxic differentiation. However, the histamine release in response to mastoparan was still observable, thus MCs are still responsive (Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref> in Supplementary Material). It was shown in addition that gene expressions of important pro-inflammatory cytokines, i.e., <italic>il-6</italic> and <italic>tnf-</italic>&#x003B1; and also <italic>vegf</italic>, one of the most important vascular permeability factors, were downregulated after physioxic differentiation (Figures <xref ref-type="fig" rid="F3">3</xref>B&#x02013;D). In good correlation to our data, the differentiation of dendritic cells under hypoxia strongly reduced cytokine levels, e.g., IL-6, TNF-&#x003B1;, and IL-1&#x003B2; under low oxygen concentrations (defined as 1% O<sub>2</sub>), proving that hypoxia has a major influence on cytokine production (<xref ref-type="bibr" rid="B48">48</xref>). We suggest that the physioxically differentiated phenotype with less stored histamine, less ROS production in response to different stimuli and decreased gene expression of <italic>hif-1</italic>&#x003B1; and target genes, including important proinflammatory cytokines like <italic>il-6</italic> and <italic>tnf-</italic>&#x003B1; reflects the tissue status of MCs in <italic>in vivo</italic>. Since the differentiation of blood-derived monocytes into tissue macrophages under normoxia increases HIF and its target gene VEGF levels during the differentiation (<xref ref-type="bibr" rid="B63">63</xref>), atmospheric oxygen concentrations, namely normoxia, which are normally used to differentiate MCs <italic>in vitro</italic>, might reflect a stress situation for the cell due to an excessive oxygen level. Normoxia might, thus, resemble physiologically a hyperoxic state that provoke oxygen stress in MCs and explain their significant role in hyperoxia-induced lung injury (<xref ref-type="bibr" rid="B64">64</xref>). Oxygen stress may cause an upregulation of intracellular histamine levels, ROS production and various genes with all its consequences for immune cell recruitment, antimicrobial defense upon infection, and impact on tissue injury. However, the detailed consequences of MC differentiation under physioxia on MC functionality in response to infection and inflammation still needs to be investigated more in detail in future studies. Furthermore, it is still unclear if there might be differences to oxygen stress response in mucosal MCs versus connective tissue MCs.</p>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>Our data show that physiological oxygen conditions substantially affect the maturation of MCs with regard to differentiation rate, gene expression of <italic>hif-1</italic>&#x003B1; and its target genes as well as <italic>foxo3</italic> and <italic>vhl</italic>, ROS production and cellular histamine storage. We could shed light on the relevance of experiments focusing on the key role of oxygen in cell culture. Finally, the differentiation under physiological conditions produces a different MC phenotype in comparison to normoxic differentiation, which more reflects the <italic>in vivo</italic> phenotype preferred for further application-oriented studies.</p>
</sec>
<sec id="S6">
<title>Ethics Statement</title>
<p>This study was carried out in accordance with the recommendations of Nds. Landesamt f&#x000FC;r Verbraucherschutz und Lebensmittelsicherheit. The protocol was approved by the local ethical commission of Lower Saxony.</p>
</sec>
<sec id="S7" sec-type="author-contributor">
<title>Author Contributions</title>
<p>MK-B, KB-H, HM, and HN: conceived and designed the experiments; HM, KB-H, KS, KM, and HF: performed the experiments; HM, KM, MK-B, and KB-H: analyzed the data; HM, KB-H, and MK-B: wrote the paper. All authors proofread the paper.</p>
</sec>
<sec id="S8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>HM was funded by the &#x0201C;Gesellschaft der Freunde der Tier&#x000E4;rztlichen Hochschule Hannover e.V.&#x0201D;</p>
</ack>
<sec id="S9" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at <uri xlink:href="http://www.frontiersin.org/article/10.3389/fimmu.2017.01665/full&#x00023;supplementary-material">http://www.frontiersin.org/article/10.3389/fimmu.2017.01665/full&#x00023;supplementary-material</uri>.</p>
<supplementary-material xlink:href="Image_1.tif" id="SM1" mimetype="applicationn/tif" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S1</label>
<caption><p>Intracellular histamine storage after physioxic differentiation (Ctr) and stimulated with the mast cell (MC)-degranulating peptide mastoparan, measured by high performance liquid chromatography. The amount of intracellular stored histamine is significantly reduced in MCs differentiated under low oxygen levels. The histamine release from granules in response to mastoparan was still observable. Depicted are mean values and SEM from cells of <italic>n</italic>&#x02009;&#x0003D;&#x02009;3 individual experiments (six mice, two mice pooled for each batch).</p></caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urb</surname> <given-names>M</given-names></name> <name><surname>Sheppard</surname> <given-names>DC</given-names></name></person-group>. <article-title>The role of mast cells in the defence against pathogens</article-title>. <source>PLoS Pathog</source> (<year>2012</year>) <volume>8</volume>(<issue>4</issue>):<fpage>e1002619</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002619</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krystel-Whittemore</surname> <given-names>M</given-names></name> <name><surname>Dileepan</surname> <given-names>KN</given-names></name> <name><surname>Wood</surname> <given-names>JG</given-names></name></person-group>. <article-title>Mast cell: a multi-functional master cell</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>620</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00620</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname> <given-names>Y</given-names></name> <name><surname>Shimada</surname> <given-names>M</given-names></name> <name><surname>Hatanaka</surname> <given-names>K</given-names></name> <name><surname>Miyano</surname> <given-names>Y</given-names></name></person-group>. <article-title>Development of mast cells from grafted bone marrow cells in irradiated mice</article-title>. <source>Nature</source> (<year>1977</year>) <volume>268</volume>:<fpage>442</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1038/268442a0</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname> <given-names>Y</given-names></name></person-group>. <article-title>Heterogeneity of mast cells and phenotypic changes between subpopulations</article-title>. <source>Ann Rev Immunol</source> (<year>1989</year>) <volume>7</volume>:<fpage>59</fpage>.<pub-id pub-id-type="doi">10.1146/annurev.iy.07.040189.000423</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirshenbaum</surname> <given-names>AS</given-names></name> <name><surname>Goff</surname> <given-names>JP</given-names></name> <name><surname>Kessler</surname> <given-names>SW</given-names></name> <name><surname>Mican</surname> <given-names>JM</given-names></name> <name><surname>Zsebo</surname> <given-names>KM</given-names></name> <name><surname>Metcalfe</surname> <given-names>DD</given-names></name></person-group>. <article-title>Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34&#x0002B; pluripotent progenitor cells</article-title>. <source>J Immunol</source> (<year>1992</year>) <volume>148</volume>(<issue>3</issue>):<fpage>772</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">1370517</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Metcalfe</surname> <given-names>DD</given-names></name> <name><surname>Costa</surname> <given-names>JJ</given-names></name> <name><surname>Burd</surname> <given-names>PR</given-names></name></person-group>. <article-title>Mast cell and basophils</article-title>. In: <person-group person-group-type="editor"><name><surname>Gallin</surname> <given-names>JI</given-names></name> <name><surname>Goldstein</surname> <given-names>IM</given-names></name> <name><surname>Snyderman</surname> <given-names>R</given-names></name></person-group>, editors. <source>Inflammation: Basic Principles and Clinical Correlates</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Raven Press Ltd</publisher-name> (<year>1992</year>). <fpage>709</fpage> p.</citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname> <given-names>EZ</given-names></name> <name><surname>Jamur</surname> <given-names>MC</given-names></name> <name><surname>Oliver</surname> <given-names>C</given-names></name></person-group>. <article-title>Mast cell function: a new vision of an old cell</article-title>. <source>J Histochem Cytochem</source> (<year>2014</year>) <volume>62</volume>(<issue>10</issue>):<fpage>698</fpage>&#x02013;<lpage>738</lpage>.<pub-id pub-id-type="doi">10.1369/0022155414545334</pub-id><pub-id pub-id-type="pmid">25062998</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname> <given-names>LB</given-names></name></person-group>. <article-title>Analysis of MC(T) and MC(TC) mast cells in tissue</article-title>. <source>Methods Mol Biol</source> (<year>2006</year>) <volume>315</volume>:<fpage>53</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">16110148</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Farrell</surname> <given-names>AM</given-names></name> <name><surname>Ichihara</surname> <given-names>M</given-names></name> <name><surname>Mui</surname> <given-names>AL</given-names></name> <name><surname>Miyajima</surname> <given-names>A</given-names></name></person-group>. <article-title>Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response</article-title>. <source>Blood</source> (<year>1996</year>) <volume>87</volume>(<issue>9</issue>):<fpage>3655</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">8611690</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lantz</surname> <given-names>CS</given-names></name> <name><surname>Boesiger</surname> <given-names>J</given-names></name> <name><surname>Song</surname> <given-names>CH</given-names></name> <name><surname>Mach</surname> <given-names>N</given-names></name> <name><surname>Kobayashi</surname> <given-names>T</given-names></name> <name><surname>Mulligan</surname> <given-names>RC</given-names></name> <etal/></person-group> <article-title>Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites</article-title>. <source>Nature</source> (<year>1998</year>) <volume>392</volume>(<issue>6671</issue>):<fpage>90</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1038/32190</pub-id><pub-id pub-id-type="pmid">9510253</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ullrich</surname> <given-names>A</given-names></name> <name><surname>Schlessinger</surname> <given-names>J</given-names></name></person-group>. <article-title>Signal transduction by receptors with tyrosine kinase activity</article-title>. <source>Cell</source> (<year>1990</year>) <volume>61</volume>:<fpage>203</fpage>.<pub-id pub-id-type="doi">10.1016/0092-8674(90)90801-K</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name> <name><surname>Wu</surname> <given-names>K</given-names></name> <name><surname>He</surname> <given-names>W</given-names></name> <name><surname>Gao</surname> <given-names>Y</given-names></name> <name><surname>Huang</surname> <given-names>W</given-names></name> <name><surname>Lin</surname> <given-names>X</given-names></name> <etal/></person-group> <article-title>Transforming growth factor beta 1 plays an important role in inducing CD4&#x0002B;CD25&#x0002B;forhead box P3&#x0002B; regulatory T cells by mast cells</article-title>. <source>Clin Exp Immunol</source> (<year>2010</year>) <volume>161</volume>:<fpage>490</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04190.x</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname> <given-names>CL</given-names></name> <name><surname>Collington</surname> <given-names>SJ</given-names></name> <name><surname>Brown</surname> <given-names>JK</given-names></name> <name><surname>Miller</surname> <given-names>HR</given-names></name> <name><surname>Al-Kashi</surname> <given-names>A</given-names></name> <name><surname>Clark</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>(<issue>12</issue>):<fpage>1961</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20042407</pub-id><pub-id pub-id-type="pmid">15955837</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlos</surname> <given-names>D</given-names></name> <name><surname>Frantz</surname> <given-names>FG</given-names></name> <name><surname>Souza-J&#x000FA;nior</surname> <given-names>DA</given-names></name> <name><surname>Jamur</surname> <given-names>MC</given-names></name> <name><surname>Oliver</surname> <given-names>C</given-names></name> <name><surname>Ramos</surname> <given-names>SG</given-names></name> <etal/></person-group> <article-title>TLR2-dependent mast cell activation contributes to the control of <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Microbes Infect</source> (<year>2009</year>) <volume>11</volume>(<issue>8&#x02013;9</issue>):<fpage>770</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.micinf.2009.04.025</pub-id><pub-id pub-id-type="pmid">19442756</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broudy</surname> <given-names>VC</given-names></name></person-group>. <article-title>Stem cell factor and hematopoiesis</article-title>. <source>Blood</source> (<year>1997</year>) <volume>90</volume>(<issue>4</issue>):<fpage>1345</fpage>&#x02013;<lpage>64</lpage>.</citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okayama</surname> <given-names>Y</given-names></name> <name><surname>Kawakami</surname> <given-names>T</given-names></name></person-group>. <article-title>Development, migration, and survival of mast cells</article-title>. <source>Immunol Res</source> (<year>2006</year>) <volume>34</volume>(<issue>2</issue>):<fpage>97</fpage>&#x02013;<lpage>115</lpage>.<pub-id pub-id-type="doi">10.1385/IR:34:2:97</pub-id><pub-id pub-id-type="pmid">16760571</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname> <given-names>J-I</given-names></name> <name><surname>Gabrilovich</surname> <given-names>DI</given-names></name></person-group>. <article-title>The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity</article-title>. <source>Eur J Immunol</source> (<year>2010</year>) <volume>40</volume>(<issue>11</issue>):<fpage>2969</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201040895</pub-id><pub-id pub-id-type="pmid">21061430</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname> <given-names>TJ</given-names></name> <name><surname>Fleming</surname> <given-names>ML</given-names></name> <name><surname>Malek</surname> <given-names>TR</given-names></name></person-group>. <article-title>Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family</article-title>. <source>J Immunol</source> (<year>1993</year>) <volume>151</volume>(<issue>5</issue>):<fpage>2399</fpage>&#x02013;<lpage>408</lpage>.<pub-id pub-id-type="pmid">8360469</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carreau</surname> <given-names>A</given-names></name> <name><surname>Hafny-Rahbi</surname> <given-names>BEl</given-names></name> <name><surname>Matejuk</surname> <given-names>A</given-names></name> <name><surname>Grillon</surname> <given-names>C</given-names></name> <name><surname>Kieda</surname> <given-names>C</given-names></name></person-group>. <article-title>Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia</article-title>. <source>J Cell Mol Med</source> (<year>2011</year>) <volume>15</volume>(<issue>6</issue>):<fpage>1239</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01258.x</pub-id><pub-id pub-id-type="pmid">21251211</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lone</surname> <given-names>AG</given-names></name> <name><surname>Atci</surname> <given-names>E</given-names></name> <name><surname>Renslow</surname> <given-names>R</given-names></name> <name><surname>Beyenal</surname> <given-names>H</given-names></name> <name><surname>Noh</surname> <given-names>S</given-names></name> <name><surname>Fransson</surname> <given-names>B</given-names></name> <etal/></person-group> <article-title><italic>Staphylococcus aureus</italic> induces hypoxia and cellular damage in porcine dermal explants</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>(<issue>6</issue>):<fpage>2531</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.03075-14</pub-id><pub-id pub-id-type="pmid">25847960</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000F6;llerherm</surname> <given-names>H</given-names></name> <name><surname>Branitzki-Heinemann</surname> <given-names>K</given-names></name> <name><surname>Brogden</surname> <given-names>G</given-names></name> <name><surname>Elamin</surname> <given-names>AA</given-names></name> <name><surname>Oehlmann</surname> <given-names>W</given-names></name> <name><surname>Fuhrmann</surname> <given-names>H</given-names></name> <etal/></person-group> <article-title>Hypoxia modulates the response of mast cells to <italic>Staphylococcus aureus</italic> infection</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>541</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00541</pub-id><pub-id pub-id-type="pmid">28553287</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olszewski</surname> <given-names>MB</given-names></name> <name><surname>Groot</surname> <given-names>AJ</given-names></name> <name><surname>Dastych</surname> <given-names>J</given-names></name> <name><surname>Knol</surname> <given-names>EF</given-names></name></person-group>. <article-title>TNF trafficking to human mast cell granules: mature chain-dependent endocytosis</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>(<issue>9</issue>):<fpage>5701</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.9.5701</pub-id><pub-id pub-id-type="pmid">17442953</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merickel</surname> <given-names>A</given-names></name> <name><surname>Edwards</surname> <given-names>RH</given-names></name></person-group>. <article-title>Transport of histamine by vesicular monoamine transporter-2</article-title>. <source>Neuropharmacology</source> (<year>1995</year>) <volume>34</volume>(<issue>11</issue>):<fpage>1543</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/0028-3908(95)00148-Y</pub-id><pub-id pub-id-type="pmid">8606801</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norrby</surname> <given-names>K</given-names></name></person-group>. <article-title>Mast cells and angiogenesis</article-title>. <source>APMIS</source> (<year>2002</year>) <volume>110</volume>(<issue>5</issue>):<fpage>355</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1034/j.1600-0463.2002.100501.x</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strieter</surname> <given-names>RM</given-names></name> <name><surname>Kunkel</surname> <given-names>SL</given-names></name> <name><surname>Bone</surname> <given-names>RC</given-names></name></person-group>. <article-title>Role of tumor necrosis factor alpha in disease states and inflammation</article-title>. <source>Crit Care Med</source> (<year>1993</year>) <volume>21</volume>:<fpage>S447</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1097/00003246-199310001-00006</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname> <given-names>GL</given-names></name></person-group>. <article-title>HIF-1 and mechanisms of hypoxia sensing</article-title>. <source>Curr Opin Cell Biol</source> (<year>2001</year>) <volume>13</volume>:<fpage>167</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/S0955-0674(00)00194-0</pub-id><pub-id pub-id-type="pmid">11248550</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname> <given-names>GL</given-names></name></person-group>. <article-title>Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology</article-title>. <source>Annu Rev Pathol</source> (<year>2014</year>) <volume>9</volume>:<fpage>47</fpage>&#x02013;<lpage>71.1</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-pathol-012513-104720</pub-id><pub-id pub-id-type="pmid">23937437</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manalo</surname> <given-names>DJ</given-names></name> <name><surname>Rowan</surname> <given-names>A</given-names></name> <name><surname>Lavoie</surname> <given-names>T</given-names></name> <name><surname>Natarajan</surname> <given-names>L</given-names></name> <name><surname>Kelly</surname> <given-names>BD</given-names></name> <name><surname>Ye</surname> <given-names>SQ</given-names></name> <etal/></person-group> <article-title>Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1</article-title>. <source>Blood</source> (<year>2005</year>) <volume>105</volume>:<fpage>659</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2004-07-2958</pub-id><pub-id pub-id-type="pmid">15374877</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname> <given-names>PH</given-names></name> <name><surname>Wiesener</surname> <given-names>MS</given-names></name> <name><surname>Chang</surname> <given-names>GW</given-names></name> <name><surname>Clifford</surname> <given-names>SC</given-names></name> <name><surname>Vaux</surname> <given-names>EC</given-names></name> <name><surname>Cockman</surname> <given-names>ME</given-names></name> <etal/></person-group> <article-title>The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis</article-title>. <source>Nature</source> (<year>1999</year>) <volume>399</volume>(<issue>6733</issue>):<fpage>271</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/20459</pub-id><pub-id pub-id-type="pmid">10353251</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peyssonnaux</surname> <given-names>C</given-names></name> <name><surname>Datta</surname> <given-names>V</given-names></name> <name><surname>Cramer</surname> <given-names>T</given-names></name> <name><surname>Doedens</surname> <given-names>A</given-names></name> <name><surname>Theodorakis</surname> <given-names>EA</given-names></name> <name><surname>Gallo</surname> <given-names>RL</given-names></name> <etal/></person-group> <article-title>HIF-1&#x003B1; expression regulates the bactericidal capacity of phagocytes</article-title>. <source>J Clin Invest</source> (<year>2005</year>) <volume>115</volume>(<issue>7</issue>):<fpage>1806</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1172/JCI23865</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zinkernagel</surname> <given-names>AS</given-names></name> <name><surname>Johnson</surname> <given-names>RS</given-names></name> <name><surname>Nizet</surname> <given-names>V</given-names></name></person-group>. <article-title>Hypoxia inducible factor (HIF) function in innate immunity and infection</article-title>. <source>J Mol Med (Berl)</source> (<year>2007</year>) <volume>85</volume>(<issue>12</issue>):<fpage>1339</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1007/s00109-007-0282-2</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname> <given-names>T</given-names></name> <name><surname>Yamanishi</surname> <given-names>Y</given-names></name> <name><surname>Clausen</surname> <given-names>BE</given-names></name> <name><surname>F&#x000F6;rster</surname> <given-names>I</given-names></name> <name><surname>Pawlinski</surname> <given-names>R</given-names></name> <name><surname>Mackman</surname> <given-names>N</given-names></name> <etal/></person-group> <article-title>HIF-1alpha is essential for myeloid cell-mediated inflammation</article-title>. <source>Cell</source> (<year>2003</year>) <volume>112</volume>(<issue>5</issue>):<fpage>645</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00154-5</pub-id><pub-id pub-id-type="pmid">12628185</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walmsley</surname> <given-names>SR</given-names></name> <name><surname>Print</surname> <given-names>C</given-names></name> <name><surname>Farahi</surname> <given-names>N</given-names></name> <name><surname>Peyssonnaux</surname> <given-names>C</given-names></name> <name><surname>Johnson</surname> <given-names>RS</given-names></name> <name><surname>Cramer</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>:<fpage>105</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20040624</pub-id><pub-id pub-id-type="pmid">15630139</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Branitzki-Heinemann</surname> <given-names>K</given-names></name> <name><surname>M&#x000F6;llerherm</surname> <given-names>H</given-names></name> <name><surname>V&#x000F6;llger</surname> <given-names>L</given-names></name> <name><surname>Husein</surname> <given-names>DM</given-names></name> <name><surname>de Buhr</surname> <given-names>N</given-names></name> <name><surname>Blodkamp</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Formation of neutrophil extracellular traps under low oxygen level</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>518</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2016.00518</pub-id><pub-id pub-id-type="pmid">27933059</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von K&#x000F6;ckritz-Blickwede</surname> <given-names>M</given-names></name> <name><surname>Goldmann</surname> <given-names>O</given-names></name> <name><surname>Thulin</surname> <given-names>P</given-names></name> <name><surname>Heinemann</surname> <given-names>K</given-names></name> <name><surname>Norrby-Teglund</surname> <given-names>A</given-names></name> <name><surname>Rohde</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Phagocytosis independent antimicrobial activity of mast cells by means of extracellular trap formation</article-title>. <source>Blood</source> (<year>2008</year>) <volume>111</volume>:<fpage>3070</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2007-07-104018</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeitouni</surname> <given-names>NE</given-names></name> <name><surname>Fandrey</surname> <given-names>J</given-names></name> <name><surname>Naim</surname> <given-names>HY</given-names></name> <name><surname>von K&#x000F6;ckritz-Blickwede</surname> <given-names>M</given-names></name></person-group>. <article-title>Measuring oxygen levels in Caco-2 cultures</article-title>. <source>Hypoxia</source> (<year>2015</year>) <volume>3</volume>:<fpage>53</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.2147/HP.S85625</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gueck</surname> <given-names>T</given-names></name> <name><surname>Aschenbach</surname> <given-names>JR</given-names></name> <name><surname>Fuhrmann</surname> <given-names>H</given-names></name></person-group>. <article-title>Influence of vitamin E on mast cell mediator release</article-title>. <source>Vet Dermatol</source> (<year>2002</year>) <volume>13</volume>:<fpage>301</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-3164.2002.00307</pub-id><pub-id pub-id-type="pmid">12464062</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dejean</surname> <given-names>AS</given-names></name> <name><surname>Hedrick</surname> <given-names>SM</given-names></name> <name><surname>Kerdiles</surname> <given-names>YM</given-names></name></person-group>. <article-title>Highly specialized role of forkhead box O transcription factors in the immune system</article-title>. <source>Antioxid Redox Signal</source> (<year>2011</year>) <volume>14</volume>(<issue>4</issue>):<fpage>663</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1089/ars.2010.3414</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Cai</surname> <given-names>X</given-names></name> <name><surname>Hu</surname> <given-names>B</given-names></name> <name><surname>Mei</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>D</given-names></name> <name><surname>Ouyang</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>Forkhead Transcription Factor 3a (FOXO3a) Modulates Hypoxia Signaling via Up-regulation of the von Hippel-Lindau Gene (VHL)</article-title>. <source>J Biol Chem</source> (<year>2016</year>) <volume>291</volume>(<issue>49</issue>):<fpage>25692</fpage>&#x02013;<lpage>705</lpage>.</citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schieber</surname> <given-names>M</given-names></name> <name><surname>Chandel</surname> <given-names>NS</given-names></name></person-group>. <article-title>ROS function in redox signaling and oxidative stress</article-title>. <source>Curr Biol</source> (<year>2014</year>) <volume>24</volume>(<issue>10</issue>):<fpage>R453</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.cub.2014.03.034</pub-id><pub-id pub-id-type="pmid">24845678</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname> <given-names>M</given-names></name> <name><surname>Siddiqui</surname> <given-names>MR</given-names></name> <name><surname>Tran</surname> <given-names>K</given-names></name> <name><surname>Reddy</surname> <given-names>SP</given-names></name> <name><surname>Malik</surname> <given-names>AB</given-names></name></person-group>. <article-title>Reactive oxygen species in inflammation and tissue injury</article-title>. <source>Antioxid Redox Signal</source> (<year>2014</year>) <volume>20</volume>(<issue>7</issue>):<fpage>1126</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1089/ars.2012.5149</pub-id><pub-id pub-id-type="pmid">23991888</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zenewicz</surname> <given-names>LA</given-names></name></person-group>. <article-title>Oxygen levels and immunological studies</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>324</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00324</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname> <given-names>L</given-names></name> <name><surname>Fuehr</surname> <given-names>K</given-names></name></person-group>. <article-title>Low oxygen concentration extends the lifespan of cultured human diploid cells</article-title>. <source>Nature</source> (<year>1977</year>) <volume>267</volume>:<fpage>423</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/267423a0</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mecklenburgh</surname> <given-names>KI</given-names></name> <name><surname>Walmsley</surname> <given-names>SR</given-names></name> <name><surname>Cowburn</surname> <given-names>AS</given-names></name> <name><surname>Wiesener</surname> <given-names>M</given-names></name> <name><surname>Upton</surname> <given-names>PD</given-names></name> <name><surname>Reed</surname> <given-names>BJ</given-names></name> <etal/></person-group> <article-title>Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis</article-title>. <source>Blood</source> (<year>2002</year>) <volume>100</volume>(<issue>8</issue>):<fpage>3008</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-02-0454</pub-id><pub-id pub-id-type="pmid">12351415</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lengner</surname> <given-names>CJ</given-names></name> <name><surname>Gimelbrant</surname> <given-names>AA</given-names></name> <name><surname>Erwin</surname> <given-names>JA</given-names></name> <name><surname>Cheng</surname> <given-names>AW</given-names></name> <name><surname>Guenther</surname> <given-names>MG</given-names></name> <name><surname>Welstead</surname> <given-names>GG</given-names></name> <etal/></person-group> <article-title>Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations</article-title>. <source>Cell</source> (<year>2010</year>) <volume>141</volume>(<issue>5</issue>):<fpage>872</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2010.04.010</pub-id><pub-id pub-id-type="pmid">20471072</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gornostaeva</surname> <given-names>AN</given-names></name> <name><surname>Andreeva</surname> <given-names>ER</given-names></name> <name><surname>Bobyleva</surname> <given-names>PI</given-names></name> <name><surname>Buravkova</surname> <given-names>LB</given-names></name></person-group>. <article-title>Interaction of allogeneic adipose tissue-derived stromal cells and unstimulated immune cells in vitro: the impact of cell-to-cell contact and hypoxia in the local milieu</article-title>. <source>Cytotechnology</source> (<year>2017</year>).<pub-id pub-id-type="doi">10.1007/s10616-017-0144-x</pub-id><pub-id pub-id-type="pmid">28975481</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Je&#x0017E;</surname> <given-names>M</given-names></name> <name><surname>Ro&#x0017E;man</surname> <given-names>P</given-names></name> <name><surname>Ivanovi&#x00107;</surname> <given-names>Z</given-names></name> <name><surname>Bas</surname> <given-names>T</given-names></name></person-group>. <article-title>Concise review: the role of oxygen in hematopoietic stem cell physiology</article-title>. <source>J Cell Physiol</source> (<year>2015</year>) <volume>230</volume>(<issue>9</issue>):<fpage>1999</fpage>&#x02013;<lpage>2005</lpage>.<pub-id pub-id-type="doi">10.1002/jcp.24953</pub-id><pub-id pub-id-type="pmid">25655806</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000F6;hler</surname> <given-names>T</given-names></name> <name><surname>Reizis</surname> <given-names>B</given-names></name> <name><surname>Johnson</surname> <given-names>RS</given-names></name> <name><surname>Weighardt</surname> <given-names>H</given-names></name> <name><surname>F&#x000F6;rster</surname> <given-names>I</given-names></name></person-group>. <article-title>Influence of hypoxia-inducible factor 1&#x003B1; on dendritic cell differentiation and migration</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>(<issue>5</issue>):<fpage>1226</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201142053</pub-id><pub-id pub-id-type="pmid">22539295</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>JH</given-names></name></person-group>. <article-title>Chemosensory regulation of development in <italic>C. elegans</italic></article-title>. <source>Bioessays</source> (<year>1993</year>) <volume>15</volume>(<issue>12</issue>):<fpage>791</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1002/bies.950151204</pub-id><pub-id pub-id-type="pmid">8141797</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dansen</surname> <given-names>TB</given-names></name> <name><surname>Burgering</surname> <given-names>BM</given-names></name></person-group>. <article-title>Unravelling the tumor-suppressive functions of FOXO proteins</article-title>. <source>Trends Cell Biol</source> (<year>2008</year>) <volume>18</volume>:<fpage>421</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.tcb.2008.07.004</pub-id><pub-id pub-id-type="pmid">18715783</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hagenbuchner</surname> <given-names>J</given-names></name> <name><surname>Ausserlechner</surname> <given-names>MJ</given-names></name></person-group>. <article-title>Mitochondria and FOXO3: breath or die</article-title>. <source>Front Physiol</source> (<year>2013</year>) <volume>4</volume>:<fpage>147</fpage>.<pub-id pub-id-type="doi">10.3389/fphys.2013.00147</pub-id><pub-id pub-id-type="pmid">23801966</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>KS</given-names></name> <name><surname>Binderup</surname> <given-names>T</given-names></name> <name><surname>Jensen</surname> <given-names>KT</given-names></name> <name><surname>Therkelsen</surname> <given-names>I</given-names></name> <name><surname>Borup</surname> <given-names>R</given-names></name> <name><surname>Nilsson</surname> <given-names>E</given-names></name> <etal/></person-group> <article-title>FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</article-title>. <source>EMBOJ</source> (<year>2011</year>) <volume>30</volume>:<fpage>4554</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/emboj.2011.323</pub-id><pub-id pub-id-type="pmid">21915097</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferber</surname> <given-names>EC</given-names></name> <name><surname>Peck</surname> <given-names>B</given-names></name> <name><surname>Delpuech</surname> <given-names>O</given-names></name> <name><surname>Bell</surname> <given-names>GP</given-names></name> <name><surname>East</surname> <given-names>P</given-names></name> <name><surname>Schulze</surname> <given-names>A</given-names></name></person-group>. <article-title>FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression</article-title>. <source>Cell Death Differ</source> (<year>2012</year>) <volume>19</volume>:<fpage>968</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1038/cdd.2011.179</pub-id><pub-id pub-id-type="pmid">22139133</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname> <given-names>WJ</given-names></name> <name><surname>Harris</surname> <given-names>IS</given-names></name> <name><surname>Mak</surname> <given-names>TW</given-names></name></person-group>. <article-title>FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2</article-title>. <source>Mol Cell</source> (<year>2007</year>) <volume>28</volume>:<fpage>941</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.molcel.2007.10.035</pub-id><pub-id pub-id-type="pmid">18158893</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohchi</surname> <given-names>C</given-names></name> <name><surname>Inagawa</surname> <given-names>H</given-names></name> <name><surname>Nishizawa</surname> <given-names>T</given-names></name> <name><surname>Soma</surname> <given-names>G</given-names></name></person-group>. <article-title>ROS and innate immunity</article-title>. <source>Anticancer Res</source> (<year>2009</year>) <volume>29</volume>(<issue>3</issue>):<fpage>817</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">19414314</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname> <given-names>CE</given-names></name> <name><surname>Halliwell</surname> <given-names>B</given-names></name> <name><surname>Borish</surname> <given-names>ET</given-names></name> <name><surname>Pryor</surname> <given-names>WA</given-names></name> <name><surname>Ames</surname> <given-names>BN</given-names></name> <name><surname>Saul</surname> <given-names>RL</given-names></name> <etal/></person-group> <article-title>Oxygen radicals and human disease</article-title>. <source>Ann Intern Med</source> (<year>1987</year>) <volume>107</volume>:<fpage>526</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.7326/0003-4819-107-4-526</pub-id><pub-id pub-id-type="pmid">3307585</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname> <given-names>GYN</given-names></name> <name><surname>Islam</surname> <given-names>DMF</given-names></name> <name><surname>Quastel</surname> <given-names>JH</given-names></name></person-group>. <article-title>Biochemical aspects of phagocytosis</article-title>. <source>Nature</source> (<year>1961</year>) <volume>192</volume>:<fpage>535</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1038/192535a0</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chelombitko</surname> <given-names>MA</given-names></name> <name><surname>Fedorov</surname> <given-names>AV</given-names></name> <name><surname>Ilyinskaya</surname> <given-names>OP</given-names></name> <name><surname>Zinovkin</surname> <given-names>RA</given-names></name> <name><surname>Chernyak</surname> <given-names>BV</given-names></name></person-group>. <article-title>Role of reactive oxygen species in mast cell degranulation</article-title>. <source>Biochemistry (Mosc)</source> (<year>2016</year>) <volume>81</volume>(<issue>12</issue>):<fpage>1564</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1134/S000629791612018X</pub-id><pub-id pub-id-type="pmid">28259134</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname> <given-names>HJ</given-names></name> <name><surname>Fukuto</surname> <given-names>JM</given-names></name> <name><surname>Torres</surname> <given-names>M</given-names></name></person-group>. <article-title>Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers</article-title>. <source>Am J Physiol Cell Physiol</source> (<year>2004</year>) <volume>287</volume>:<fpage>C246</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1152/ajpcell.00516.2003</pub-id><pub-id pub-id-type="pmid">15238356</pub-id></citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sena</surname> <given-names>LA</given-names></name> <name><surname>Chandel</surname> <given-names>NS</given-names></name></person-group>. <article-title>Physiological roles of mitochondrial reactive oxygen species</article-title>. <source>Mol Cell</source> (<year>2012</year>) <volume>48</volume>(<issue>2</issue>):<fpage>158</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.molcel.2012.09.025</pub-id><pub-id pub-id-type="pmid">23102266</pub-id></citation></ref>
<ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>W</given-names></name> <name><surname>Gan</surname> <given-names>X</given-names></name> <name><surname>Su</surname> <given-names>G</given-names></name> <name><surname>Wanling</surname> <given-names>G</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Hei</surname> <given-names>Z</given-names></name> <etal/></person-group> <article-title>The interaction between oxidative stress and mast cell activation plays a role in acute lung injuries induced by intestinal ischemia-reperfusion</article-title>. <source>J Surg Res</source> (<year>2014</year>) <volume>187</volume>(<issue>2</issue>):<fpage>542</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1016/j.jss.2013.10.033</pub-id><pub-id pub-id-type="pmid">24275574</pub-id></citation></ref>
<ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guzy</surname> <given-names>RD</given-names></name> <name><surname>Schumacker</surname> <given-names>PT</given-names></name></person-group>. <article-title>Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia</article-title>. <source>Exp Physiol</source> (<year>2006</year>) <volume>91</volume>(<issue>5</issue>):<fpage>807</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1113/expphysiol.2006.033506</pub-id><pub-id pub-id-type="pmid">16857720</pub-id></citation></ref>
<ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname> <given-names>T</given-names></name> <name><surname>Hirota</surname> <given-names>K</given-names></name> <name><surname>Nishi</surname> <given-names>K</given-names></name> <name><surname>Takabuchi</surname> <given-names>S</given-names></name> <name><surname>Yamada</surname> <given-names>H</given-names></name> <name><surname>Oda</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Activation of hypoxia-inducible factor 1 during macrophage differentiation</article-title>. <source>Am J Physiol Cell Physiol</source> (<year>2006</year>) <volume>291</volume>:<fpage>C104</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1152/ajpcell.00614.2005</pub-id></citation></ref>
<ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veerappan</surname> <given-names>A</given-names></name> <name><surname>Thompson</surname> <given-names>M</given-names></name> <name><surname>Savage</surname> <given-names>AR</given-names></name> <name><surname>Silverman</surname> <given-names>ML</given-names></name> <name><surname>Chan</surname> <given-names>WS</given-names></name> <name><surname>Sung</surname> <given-names>B</given-names></name> <etal/></person-group> <article-title>Mast cells and exosomes in hyperoxia-induced neonatal lung disease</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source> (<year>2016</year>) <volume>310</volume>(<issue>11</issue>):<fpage>L1218</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1152/ajplung.00299.2015</pub-id><pub-id pub-id-type="pmid">27130530</pub-id></citation></ref>
</ref-list>
</back>
</article>